Compound Care Pharmacy, Louisville, KY

Is Compound Care Pharmacy registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Compound Care Pharmacy hold a Kentucky pharmacy license?

State board of pharmacy records for Kentucky are not checked: the board releases its license rosters only on request, and its board actions page shows nothing without running scripts.

Has Compound Care Pharmacy had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 state referral letter (Jun 4, 2020) and 1 FMD-145 letter (Jun 4, 2020) for Compound Care Pharmacy. State board of pharmacy records for Kentucky are not checked: the board releases its license rosters only on request, and its board actions page shows nothing without running scripts. The state referral and handoff letters above are FDA’s letters to the state, not board actions.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Compound Care Pharmacy
Location
Louisville, KY
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
1
Warning letters on FDA’s actions page
0
Latest action on that page
Jun 4, 2020
FDA Data Dashboard inspections
0 inspections; 0 published Form 483s
Form 483 text on this page
1 Form 483, 2 observations
State board records
Not checked

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Compound Care Pharmacy, a 503A facility, with 3 dated actions.

Document
Jun 4, 2020State referral letterState Referral Letter Issued 06/04/2020Not linked by FDA
Jun 4, 2020FMD-145 letterFMD-145 Letter Issued 06/04/2020FDA copy (archived)
May 16, 2019Form 483483 Issued 05/16/2019FDA copy (archived)

A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists Compound Care Pharmacy LLC, Louisville, KY (FEI number 3006269306), matched to this page by exact name, city and state. It lists no classified inspection under this name at that site. Dashboard firm profile.

Form 483s FDA has published for this site

No published Form 483 for FEI 3006269306 was found in the dashboard’s list of published 483s on Nov 15, 2026. FDA publishes only some 483s, so this does not mean none was issued.

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 2 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection dated May 16, 2019 by FDA (dates on the form not read): 2 observations

Firm on the cover
Compound Care Pharmacy, 12121 Shelbyville Rd STE 107, Louisville, KY 40243
FEI number
3006269306
Establishment type on the cover
Sterile Compounding Pharmacy
FDA district office on the cover
Not read
Matched to this page by
firm name, city and state on the cover; linked from actions page
FDA document
Read the full 483 (Internet Archive copy FDA links)

This 483 is a scanned image. The text below is the PDF’s own text layer, which can misread characters; the PDF is the record.

Observation 1

Your firm released drug product in which the strength differs from, or its purity or quality falls below, that which it purports or is represented to possess.

Specifically,

Your firm does not have assurance that your intrathecal drug products contain safe levels of bacterial endotoxin (BET). The non-sterile active pharmacetuical ingredients (API) baclofen, bupivacaine. clonidine. hydromorphone, and morphine sulfate used in the production of those intrathccal drugs do not contain results for BET testing on their Certificates of Analysis (CoA). Due to this, and combined with the fact that you do not perform testing on your intrathecal drug products -the result is a lack of assurance that your intrathccal products produced with those API are free from BET.

Observation 2

Disinfecting agents and cleaning pacts or wipes used in the ISO 5 area arc not sterile.

Specifically,

Your firm uses <Redacted B4> and <Redacted B4> in your ISO 5 area. Neither oflhcse products is considered self-sterilizing and you do not use sterile versions, or perform sterilization actions on these cleaners. This could result in contamination of your sterile production area by microorganisms and thus risk contamination of your product.

State board of pharmacy records

State board of pharmacy records for Kentucky are not checked: the board releases its license rosters only on request, and its board actions page shows nothing without running scripts.

This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.